Copyright
©The Author(s) 2015.
World J Clin Oncol. Aug 10, 2015; 6(4): 57-63
Published online Aug 10, 2015. doi: 10.5306/wjco.v6.i4.57
Published online Aug 10, 2015. doi: 10.5306/wjco.v6.i4.57
Table 1 Sample description
| n = 29 | ||
| Average age (yr) | 74,17 (std 12.90) | |
| Range (yr) | 34-93 | |
| Sex | n | % |
| Females | 13 | 45 |
| Males | 16 | 55 |
| Tumor localization | ||
| Upper limb | 5 | 17 |
| Lower limb | 24 | 83 |
| Previous therapy | ||
| SURG + INF | 10 | 34 |
| SURG | 9 | 31 |
| SURG + CHT + INF | 7 | 24 |
| SURG + CHT | 2 | 7 |
| SURG + PERF + CHT + INF | 1 | 3 |
| Treatment type | ||
| ILI + HF | 30 | 76 |
| ILI | 4 | 14 |
| ILI + (ILI + HF) | 3 | 10 |
| Drug type | ||
| Melphalan | 11 | 38 |
| Melphalan + cisplatin | 7 | 24 |
| Melphalan + mitomicin C | 7 | 24 |
| Cisplatin | 2 | 7 |
| Melphalan + epirubicin | 1 | 3 |
| Cisplatin + mitomicin C | 1 | 3 |
Table 2 Efficacy: Tumor response one month after isolated limb infusion and hemofiltration
| n = 29 | ||
| Response | n | % |
| PR | 16 | 56 |
| SD | 7 | 22 |
| CR | 3 | 11 |
| PD | 3 | 11 |
- Citation: Cecchini S, Sarti D, Ricci S, Vergini LD, Sallei M, Serresi S, Ricotti G, Mulazzani L, Lattanzio F, Fiorentini G. Isolated limb infusion chemotherapy with or without hemofiltration for recurrent limb melanoma. World J Clin Oncol 2015; 6(4): 57-63
- URL: https://www.wjgnet.com/2218-4333/full/v6/i4/57.htm
- DOI: https://dx.doi.org/10.5306/wjco.v6.i4.57